HPV is the most common sexually transmitted infection worldwide, and most sexually active adults will be exposed to it at some point during their lives.
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Most sexually active adults will be exposed to HPV at some point during their lives, often without ever knowing it. In the majority of cases, the immune system clears the virus naturally and no health problems develop. However, certain HPV strains can persist and increase the risk of genital warts, precancerous changes and a variety of cancers affecting both men and women.
The introduction of HPV vaccination and modern screening programmes has transformed cancer prevention, allowing many HPV-related cancers to be prevented or detected at a very early stage. Despite this, HPV results, abnormal screening tests and discussions surrounding cancer risk can often cause understandable anxiety and confusion.
At The Wright Practice, we help patients understand HPV-related health concerns, assess individual risk factors, interpret screening results and navigate appropriate investigations where required. Our focus is on education, reassurance, prevention and early detection.
Human Papillomavirus (HPV) is the most common sexually transmitted infection in the world. Whilst most infections clear naturally, certain HPV strains are responsible for genital warts, precancerous changes and a range of cancers affecting both men and women.
For this reason, HPV vaccination is one of the most important preventative interventions available within modern sexual health medicine.
Gardasil 9 is the HPV vaccine currently used in many countries worldwide. It protects against nine HPV strains, including those responsible for the majority of HPV-related cancers and genital warts. HPV 16 and HPV 18 account for most HPV-related cancers, whilst HPV 6 and HPV 11 cause the majority of genital warts.
HPV is transmitted through intimate skin-to-skin contact and may be acquired through vaginal, anal or oral sex, as well as genital-to-genital contact. Because HPV is extremely common and often asymptomatic, many individuals are exposed without ever realising it.
Many people assume HPV vaccination is only relevant during adolescence. In reality, adults may still benefit significantly from vaccination, particularly those who were never vaccinated, individuals entering new relationships, men who have sex with men, people living with HIV and those seeking to reduce their future risk of HPV-related disease.
Although vaccination cannot eliminate HPV that is already present, it may still provide protection against strains not previously encountered. Extensive research has demonstrated substantial reductions in HPV infection, genital warts, cervical precancer and cervical cancer following widespread vaccination programmes.
Many experts believe that widespread HPV vaccination has the potential to dramatically reduce HPV-related cancers in future generations.
The schedule depends on age and individual circumstances.
Most adults receiving HPV vaccination privately receive a three-dose course over several months.
We can advise on the most appropriate schedule during consultation.
HPV vaccination has been extensively studied worldwide.
Hundreds of millions of doses have been administered globally and the vaccine has an excellent safety record.
Most side effects are mild and temporary.
These may include:
Serious side effects are extremely uncommon.
Few vaccines offer the opportunity to reduce the risk of multiple cancers with a single intervention.
For this reason, HPV vaccination is often one of the most valuable preventative healthcare decisions an individual can make.
Cervical screening remains one of the most successful cancer prevention programmes ever developed. The purpose of screening is not primarily to diagnose cancer, but to identify HPV infection and early cellular changes before cancer develops.
Most women who receive a positive HPV result or are told they have abnormal cells do not have cancer. In fact, the majority of abnormalities either resolve naturally or can be treated successfully when identified early. Modern screening pathways are specifically designed to detect and manage changes long before they become dangerous.
Terms such as high-risk HPV, low-grade changes, high-grade changes and colposcopy referral can understandably cause anxiety when taken out of context. Understanding the significance of a result often requires consideration of age, previous screening history and the specific abnormalities identified.
Whether you have received a high-risk HPV result, undergone colposcopy or would simply like a clearer understanding of your screening history, obtaining accurate information can often provide valuable reassurance and help ensure appropriate follow-up.
Awareness of anal HPV and anal cancer prevention has increased significantly in recent years, particularly among higher-risk groups such as men who have sex with men, individuals living with HIV, those with a history of HPV-related disease and immunocompromised patients.
Persistent infection with high-risk HPV types can lead to abnormal changes within the anal canal known as anal intraepithelial neoplasia (AIN). Whilst most cases do not progress to cancer, identifying significant abnormalities allows appropriate surveillance and treatment where required.
Anal cytology, often referred to as an anal smear test, may be considered in selected higher-risk individuals. Abnormal results sometimes require further assessment using specialist procedures such as high-resolution anoscopy. Screening recommendations continue to evolve and differ from established cervical screening programmes.
Many patients seek guidance following abnormal anal cytology results, positive HPV tests or concerns regarding future cancer risk. Understanding the significance of these findings requires consideration of the wider clinical picture rather than relying on a single test result in isolation.
Certain HPV types have been linked to cancers affecting the oropharynx, including the tonsils and base of the tongue. Although HPV-related throat cancers remain relatively uncommon, awareness has increased substantially over recent years.
Many patients become concerned after learning that they or a partner have HPV and worry about the possibility of throat cancer. In most cases there is no role for routine HPV throat testing, and a positive HPV result elsewhere does not mean that throat cancer will develop.
The most important consideration is the presence of symptoms that may require further assessment. Persistent throat discomfort, difficulty swallowing, unexplained ear pain, persistent hoarseness, a sensation of a lump in the throat or enlarged neck lymph nodes should always be assessed appropriately.
Whilst the vast majority of throat symptoms are not caused by cancer, persistent or unexplained symptoms should never be ignored and may warrant specialist ENT assessment.
Genital warts are caused by low-risk HPV types and are not associated with cancer development. However, they can cause understandable anxiety and may affect confidence, relationships and sexual wellbeing.
A diagnosis of genital warts does not imply promiscuity, infidelity or poor hygiene. HPV is extremely common and infection often occurs many years before visible warts appear, making it impossible in most cases to determine when or from whom the virus was acquired.
Treatment options vary depending on the number, size and location of lesions and may include topical therapies, cryotherapy or specialist procedures. Even after successful treatment, recurrence can occur because the virus may remain present within surrounding tissues.
Understanding transmission, recurrence and treatment expectations is often just as important as treatment itself, helping patients make informed decisions and reducing unnecessary anxiety.
One of the most common reasons patients seek advice is uncertainty about what an HPV result actually means. HPV testing, cervical screening, anal cytology and specialist investigations can generate significant anxiety when results are not fully understood.
HPV is common, and most infections never lead to serious health problems. Factors such as age, smoking status, immune function, previous HPV-related disease and screening history all influence an individual’s level of risk. For this reason, results should always be interpreted within the context of the wider clinical picture rather than in isolation.
Understanding risk is rarely as simple as having HPV or not having HPV. Different HPV strains carry different levels of risk, and the significance of a result often depends upon a combination of factors rather than a single test. Clear interpretation of results can help patients make informed decisions whilst ensuring that significant findings receive timely investigation and specialist care where required.
Wow! Dr. Dan was extremely knowledgeable and attentive to my health and well being. I’m so glad to have found him!
I have been going to Dr Wright for a number of years now. He is highly knowledgeable, compassionate, open minded and efficient, I couldn’t recommend him highly enough
I have been a patient of Doctor Dan for some time and continue to consult with him despite having left the UK. Dan has the enthusiasm and energy of a young man, whilst taking the holistic “physician” approach of an old school family doctor, equipped with the most modern insights and technology.
Dr Jain was great. Expert knowledge with practical advice
Schedule a consultation | Call: +44 (0)207 139 1833 | Email: info@thewrightpractice.com
101 Harley Street, London, W1G 6AH
Rated ★ ★ ★ ★ ★ from 192 Reviews
